A long-lasting neural probe
Researchers develop implantable device that can record a collection of individual neurons over months.
Harvard faculty are preeminent scholars and prolific inventors. In OTD, we also understand that some academic innovations need a boost to succeed commercially.
OTD’s pioneering technology accelerator programs—the Blavatnik Biomedical Accelerator and the Harvard Grid Accelerator—help bridge the development gap, providing focused funding and resources to validate and de-risk promising technologies for successful partnering.
What ultimately makes it all work? Passionate people.
Our wide network of venture capitalists and entrepreneurs—many of whom are Harvard alumni—give generously of their time and expertise, leading and investing in new startup companies, engaging with labs as Entrepreneurs in Residence or Experts in Residence, serving on our accelerator advisory committees, speaking at OTD events, and making valuable connections throughout Cambridge and Boston.
Researchers develop implantable device that can record a collection of individual neurons over months.
A look back at moments in 2023 where researchers and industry leaders came together to connect and learn; strategic collaborations, research agreements and accelerator funding were announced; and translational research made it out of the labs for societal impact.
Verve Motion has announced it has reached a significant milestone by securing $20 million in Series B funding.
Keep in touch with news and partnering opportunities from Harvard’s Office of Technology Development.